No black box warning on record for Lybalvi
As of the latest FDA labeling reviewed, Lybalvi (OLANZAPINE AND SAMIDORPHAN L-MALATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Lybalvi medicine page for the complete safety profile.